,
Freyr partnered with a leading US-based biotechnology company to deliver end-to-end global regulatory publishing support across the US, EU, and RoW regions. With over 10 dedicated Publishing FTEs, Freyr established a unified global submissions process that accelerated IND filings and ensured seamless coordination across multiple programs and markets.
The team managed expedited, high-stakes submissions with turnaround times as low as 1–5 days, while adhering to the client’s SOPs, style guides, and technology systems. This strategic collaboration enabled rapid scale-up, improved submission quality, and supported successful regulatory approvals under stringent timelines.
Download the full case study to explore the complete transformation.
Fill the form below to download the Case Study
